TANG Capital Management LLC, 10% Owner, Officer, Chief Executive Officer, Chief Financial Officer at Odonate Therapeutics, Inc. (ODT), bought 58,166 shares at $25.15 ($1.6M) on 2018-02-20, disclosed to the SEC on 2018-02-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.15 | 8,313 | $209K | 13.3% |
| 2 | $25.15 | 8,313 | $209K | 13.3% |
| 3 | $27.72 | 3,432 | $95K | 6.1% |
| 4 | $27.72 | 3,432 | $95K | 6.1% |
| 5 | $27.95 | 10,000 | $280K | 17.8% |
| 6 | $27.29 | 10,000 |
| $273K |
| 17.4% |
| 7 | $27.96 | 7,338 | $205K | 13.1% |
| 8 | $27.96 | 7,338 | $205K | 13.1% |
| Total | $27.01 avg | 58,166 | $1.6M | 100% |
| Filing → |
| RAIN | BUY | 2023-06-01 | $2.1M | — | Filing → |
| JNCE | BUY | 2023-03-14 | $151K | — | Filing → |
| ODT | SELL | 2021-11-19 | $9.5M | — | Filing → |